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Extracts of Chaetomium globosum EF18, isolated as endophytic fungus from Withania somnifera, were found
effective against Sclerotinia sclerotiorum. Ethyl acetate and methanol extracts were more effective than hexane
extract showing >80% growth inhibition. Bioactive compound (antibiotic Sch 210971, m/z 445 and λmax 290)
having antifungal activity against S. sclerotiorum has been isolated in pure form from the ethyl acetate extract
following bioassay guided fractionation. Apart from this compound other fractions of polar to medium polarity
were also found effective. Fraction no. VIII from VLC (Vacuum liquid chromatography) column of ethyl acetate
extract was most active having IC50 value 35.4 μg/ml.
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The need for new and useful compounds to provide pro-
tection and relief to crop plants from pests and thereby
sustenance of food production for human consumption
is ever growing. Plant diseases have been causing devas-
tating effects on crop plants and human life since the
human civilization evolved (Agrios 2005). To combat
such diseases, safer and greener chemicals have to be de-
veloped because conventional chemicals are posing grea-
ter threat to ecology and biodiversity and also causing ill
effects to human health. Microbes and their compounds
are emerging as alternative strategies for pest control
(Montesinos 2003).
Many endophytic fungi and their metabolites have
been reported to have insecticidal and fungicidal activity
(Kumar et al. 2008). In our effort to isolate bioactive
endophytic fungi, we isolated various endophytic fungi
from Withania somnifera, among which Chaetomium
globosum EF18 showed good activity against Scleroti-
nia sclerotiorum, Fusarium oxysporum and Rhizoctonia
solani (Kumar et al., communicated paper). S. sclerotio-
rum is non-specific and omnivorous pathogen causing* Correspondence: kaushikn@teri.res.in
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in any medium, provided the original work is pdiseases to plants belonging to 75 families, 278 genera,
and 408 species (Boland and Hall 1994). Some of the
major crops affected by S. sclerotiorum are brassicas,
potato, chickpea, pea, sunflower, beans, carrot, lettuce,
soybean, kiwifruit and grapes. Although the most com-
mon disease caused by S. sclerotiorum is white mould, yet
cottony rot, watery soft rot, stem rot, drop, crown rot,
blossom blight are also of common occurrence in crop
plants causing yield loss up to 100% (Purdy 1979). 1.5
million Tones of yield reduction due to Sclerotinia in-
fection in soybean have been reported in US during
2004 (Wrather and Koenning 2006). This paper des-
cribes the isolation of active metabolites of endophytic
fungus through bioassay mediated fractionation using
VLC, Column chromatography and preparative HPLC.
Bioactivity was tested against S. sclerotiorum during the
experimentation.Results
Ethyl acetate, methanol (a portion of EtoAc extract was
partitioned between methanol and hexane and then
assayed to see if polarity has major effect on antifun-
gal activity) and butanol extracts of endophytic fungus
C. globosum were tested at 250 μg/ml and 500 μg/ml
against S. sclerotiorum. Methanol extract showed 76.58%
mycelial growth inhibition (GI) at 500 μg/ml on 4th day,n Open Access article distributed under the terms of the Creative Commons





























Figure 1 Effect of different extracts of Chaetomium globosum isolate EF18 against plant pathogenic fungi, Sclerotinia sclerotiorum
(CD0.05 = 6.864, CD0.01 = 9.261).
Table 1 Effect of different fractions obtained from
vacuum liquid chromatography of ethyl acetate extract
of Chaetomium globosum EF18 on growth of Sclerotinia
sclerotiorum
Sl no. Fractions Growth inhibition (%) on 5th day
100 μg/ml 200 μg/ml 500 μg/ml
1 WSL 2E IV 18.8 ± 4.8 43.9 ± 5.4 70.2 ± 8.5
2 WSL 2E V 12.6 ± 6.8 39.6 ± 1.7 70.8 ± 4.4
3 WSL 2E VI 21.6 ± 1.0 32.5 ± 5.1 81.6 ± 2.4
4 WSL 2E VII 9.0 ± 3.4 61.9 ± 7.5 82.4 ± 1.4
5 WSL 2E VIII 75.6 ± 5.7 83.7 ± 1.6 95.9 ± 0.8
6 WSL 2E IX 56.0 ± 8.5 66.7 ± 5.7 84.5 ± 0.8
7 WSL 2E X 25.2 ± 6.4 52.8 ± 26.2 90.2 ± 1.4
Coefficient of variation = 25.38%.
LSD-10.461 (0.05), 13.748 (0.01); p≤0.05.
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tate extract was effective at 500 μg/ml having 75.68%
growth inhibition on 4th day. No significant difference
was observed in the growth inhibition caused by ethyl
acetate extract and methanol extract on 4th day. Butanol
extract was least effective showing 33.32% growth inhib-
ition at 500 μg/ml on 4th day. Graphical representation
of GI over no. of days is given in Figure 1.
Ethyl acetate extract was further fractionated by VLC
on silica gel. On the basis of HPLC and LC-MS analysis
it was observed that all the VLC fractions were mixtures
of many compounds. When tested for their bioactivity,
fraction WSL-2E_VIII exhibited maximum mycelial
growth inhibition of 95.9%, 83.7% and 75.6% at 500
μg/ml, 200 μg/ml and 100 μg/ml respectively (Table 1).
Fraction WSL-2E_VI, WSL-2E_VII, WSL-2E_IX and
WSL-2E_X were statistically at par and caused more
than 80% growth inhibition at 500 μg/ml. Fraction IV
and V exhibited least growth inhibition, ~70% at 500
μg/ml, among all the fractions. Figure 2 shows growth
inhibition caused by these fractions at different concen-
trations. IC50 values were calculated for these fractions
and are provided in Table 2, which shows that lowest
IC50 of 40.57 μg/ml and 35.4 μg/ml on 4
th and 5th day
respectively was observed in fraction no. VIII. Chi-square
values and regression equation have also been provided
in the Table 2. Fraction no. IX stands next to fraction
VIII showing IC50 value of 80.14 μg/ml on 5
th day of
observation.
The VLC fractions VI- X showing activity against S.
sclerotiorum were having a common peak at RT 42.3-
42.4 minutes (from Waters HPLC) (Figure 3). Corre-
lation of chemical analysis and bioassay results, it is
apparent that the compound eluting at RT 42.5 isresponsible for the antifungal activity. As depicted in the
Table 3, increased concentration― corresponds to in-
creased area of the peak― of this compound in the frac-
tion was prime cause of increased bioactivity of the
fraction. Table 4 shows the regression model and cor-
relation between increasing concentration of active
compound in the fraction and bioactivity of fraction.
Correlation coefficient (r) of 0.86 was calculated bet-
ween the % area of the compound in the HPLC chro-
matogram and biological activity at 100 μg/ml, which
says that statistically 86% of the activity in these frac-
tions is due to the compound and rest 14% is due to the
unexplained reason. LC-MS analysis suggested the mo-
lecular weight of the compound associated with peak
(RT 33.78 in LC-MS) as 445 (m/z+ 446 and m/z- 444)































































Figure 2 Graphical representations of effect different concentration of VLC fractions of C. globosum EF18 on radial growth of
S. sclerotiorum (values on Y axis are % growth inhibition).
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of growth inhibition in Sclerotinia sclerotiorum due to
the toxicant present in VLC fractions VIII, IX and X.
WSL-2E_VI _I_S1 fraction was subjected to prepa-
rative HPLC to obtain pure compound ‘A’, which was
further analyzed by NMR spectroscopy. Comparative
analysis of NMR and MASS revealed that compound ‘A’
is similar to Antibiotic Sch 210971 (m/z 445 and λmax
290) (Figure 8), which has previously been isolated from






1 WSL 2E IV 135.43 0.115 Y = 2.711
2 WSL 2E V 114.71 1.189 Y = 2.132
3 WSL 2E VI 158.74 2.037 Y = 3.132
4 WSL 2E VII 166.84 0.001 Y = 4.292
5 WSL 2E VIII 40.57 1.165 Y = 1.97 +
6 WSL 2E IX 155.26 0.399 Y = 3.008
7 WSL 2E X 220.44 1.301 Y = 6.302et al. molecular weight of the isolated compound was
445 Da and showed the protonated molecular ion at
m/z+ 446 similar to the compound isolated by us. Also
UV absorption of Sch 210971 at 220 and 295 was near
to that of our compound i.e. 226 and 288.
Discussion
Hexane extract of C. globosum has been reported as
antifungal against S. sclerotiorum and Botrytis cineria
(Nakashina et al. 1991). However we find polar extractEF18 tested against S. sclerotiorum
5th day
n equation IC50 χ
2 Regression equation
+ 1.272 X 260.31 0.577 Y = 4.818 + 1.995 X
+ 1.035 X 281.95 0.841 Y = 5.803 + 2.368 X
+ 1.423 X 243.86 5.635 Y = 5.895 + 2.469 X
+ 1.931 X 209.56 14.76 Y = 7.104 + 3.061 X
1.225 X 35.4 0.696 Y = 2.228 + 1.438 X
+ 1.373 X 80.14 0.333 Y = 2.351 + 1.235 X
+ 2.689 X 179.31 0.414 Y = 6.307 + 2.799 X
WSL 2E VIII
WSL 2E IX WSL 2E X
WSL 2E VI
WSL 2E VII
Figure 3 HPLC chromatogram of VLC fraction of ethyl acetate extract of C. globosum EF18, obtained with Waters HPLC and showing
the peak of compound (Rt 42.3) responsible for antifungal activity.
Table 3 Effect of increasing concentration of antibiotic





at *Rt 42.4 min
(λmax 288 nm)
Growth inhibition (%)
100 μg/ml 200 μg/ml 500 μg/ml
WSL 2E IV - 0.0 0.0 47.84
WSL 2E V - 0.0 0.0 33.72
WSL 2E VI 8.88 0.0 3.92 74.90
WSL 2E VII 27.6 0.0 44.31 75.29
WSL 2E VIII 30.34 76.4 82.63 88.80
WSL 2E IX 20.00 55.19 64.70 84.87
WSL 2E X 18.48 21.57 55.74 86.55
*This Rt (from Waters HPLC, C-18) corresponds to Rt 34.1 (from Dionex HPLC)
of above chromatogram.
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hexane extract against S. sclerotiorum. Antibiotic Sch
210971 has been previously reported as chemokine re-
ceptor CCR-5 inhibitor (Yang et al. 2006); however this
is the first report of antifungal activity of this compound.
HPLC has been utilized for the first time in our study
in finding out the principle component of C. globosum
responsible for antifungal activity. Previously chaetomu-
gilin D, together with three known metabolites, chaeto-
mugilin A, chaetoglobosins A and C have been isolated
by a bioassay-guided fractionation from the EtOAc ex-
tract of the cultures of C. globosum. Chaetomugilin D
also reported to have antifungal activity against Mucor
miehei (Qin et al. 2009). C. globosum an endophyte to a
medicinal plant Curcuma wenyujin has yielded chaeto-
globosin X, which showed broad antifungal activity
(Wang et al. 2012). Zhang et al. (2013) have also isolated
Table 4 Correlation coefficient and regression model between % peak area of sch210971 in different VLC fractions and
their growth inhibition property against S. sclerotiorum






WSL 2E VIII 30.34 76.4 82.63
WSL 2E IX 20.00 55.19 64.70
WSL 2E X 18.48 21.57 55.74
Regression Model % GI= −33.469 + 3.684 X
% Peak area ± 19.952
% GI = 20.194 + 2.070 X
% Peak area ± 4.14
Coefficient of determination (R) 0.740 0.954
Coefficient of correlation (r) 0.860 0.976
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found that chaetoglobosin A is having antifungal activity
against Setosphaeria turcica, causal agent of northern
corn leaf blight. Two other antifungal substances viz.
chaetoviridins A and B have been purified from cul-
ture broth of C. globosum isolated from barnyard grass.
Chaetoviridin A exhibited higher antifungal activity with
80% reduction in disease development at 62.5 μg/ml con-
centration against rice blast and wheat leaf rust and 50%
control of late blight of tomato at 125 μg/ml (Park et al.
2005), however purified fraction isolated in our experi-
ment has IC50 value of 35.4 μg/ml. In present study we
have found that Antibiotic Sch 210971 can be used as
marker for antifungal activity against S. sclerotiorum.
Role of C. globosum in biological control has been well
documented and commercial formulation has also been
developed (Soytong et al. 2001). Culture filtrate of C. glo-
bosum has been reported to successfully inhibit the my-
celial growth of Pythium ultimum in In vitro and pot
culture experiments. Chaetomin has been the princi-
ple compound responsible for this antifungal activityFigure 4 LC-MS chromatogram of purified fraction (WSL 2E VI_I_S1) o(Di-Pietro et al. 1992). Cell wall degradation caused by
beta-glucanases and carboxymethyl cellulases is one of the
possible modes of action of C. globosum against P. ulti-
mum (Inglis and Kawchuk 2002). Mode of action of Anti-
biotic Sch 210971 needs to be studied further. Antibiotic
Sch 210971 enriched fraction can be formulated as anti-
fungal biopesticide.
Materials and methods
HPLC was performed with Chromeleon Ver 6.3 pro-
gram; Dionex P580A LPG Pump; Photo Diode Array
(PDA) Detector UVD 340S detector; ASI-100T Auto-
sampler; STH 585 Column Thermostat; Eurospher 100-
C18, Knauer column. HPLC of extracts was also per-
formed on Waters HPLC system with Autosampler, 717
plus; PDA 2996 detector; System controller 600 and Em-
power2 software with polar gradient method. The sam-
ples were analyzed on a Phenomenex column (250 ×
4.60 mm, 5 μ) using mobile phase acetonitrile: water
(HPLC grade). Preparative HPLC was done with Varian
prepstar 218 pump; Microsorb 60–8 C18 column with 
btained from preparative HPLC.
Figure 5 UV spectrum of the compound ‘A’.
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jection block. LC-MS was performed on Agilent 1100
series HPLC system (pump, detector and autosampler)
with Knauer (125 mm L, 2 mm ID), prepacked with
Eurosphere- 100 C-18 (5 μm) and with integrated pre-
column and Finnigan LC Q-DECA MS detector. HPLC
grade methanol and nanopure water with ortho-phos-
phoric acid 0.15%, pH 2.0 were used for HPLC and LC-
MS. 1H NMR was recorded on Bruker DRX-500 instru-
ment operating at 500 MHz.Figure 6 m/z (H+) spectra of the purified compound ‘A’.Batch culture fermentation of C. globosum EF18 and its
extraction
Fungus was multiplied in 11.7 litres of wickerham me-
dium [Malt extract (3 g/l); Yeast extract (3 g/l); Peptone
(5 g/l); Glucose (Qualigens)-10 g/l; pH-7.2-7.4] at 24°C
for 3–4 weeks. Media chemicals were purchased from
Himedia, India. One flask of medium without the inocu-
lum was kept as control. Metabolite extraction was done
as per the protocol of Wicklow et al. (1998). Extraction
procedure has been depicted in Figure 9 as flow diagram.
WSL 2E VIII 100 µg/ ml WSL 2E IX 100 µg/ ml WSL 2E X 100 µg/ ml
Figure 7 Effect of different VLC fractions obtained from ethyl acetate extract of C. globosum EF18 on radial growth of S. sclerotiorum.
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A schematic diagram of procedure for separation and
purification is presented in Figure 10. Extract was sub-
jected to VLC and eluted with dichloromethane: metha-
nol in the following order: 100% DCM, 95:5 DCM:
MeOH, 90:10, 80:20, 70:30, 60:40, 50:50, 30:50, 25:75 and
100% MeOH. These fractions (WSL 2E I-X; Figure 10)
were dried in rotary under vacuum and investigated by
TLC and HPLC. Based on the HPLC and LC-MS profiles
of the fractions, fraction no. WSL2E VI was further puri-
fied by sephadex LH 20 (Merck) column with dichloro-
methane and methanol 50:50. Based of TLC pattern,
fractions were grouped in to 5 groups- WSL2EVI_I-V.
These 5 fractions were analyzed by HPLC and LC-MS.
Sub-fraction 1 (WSL2EVI_I) was further purified by se-
phadex column with 100% methanol followed by prepara-
tive HPLC (Figure 10). Preparative HPLC was done with
the following gradient 0–5 min 50% methanol and 5–35
min increase from 50–100% of methanol and from 35–40
100% methanol. One major compound was obtained
(compound ‘A’ in Figure 10).
Identification of antifungal Sch 210971
The Identification was done by MASS and NMR. The






























Figure 8 Structure of the antibiotic Sch 210971.ESI-MS hyphenated system. This compound corresponds
to compound of Rt. 42.5 from Waters HPLC, C-18 and to
Rt 34.1 from Dionex HPLC. The compound eluted at Rt
33.91 having m/z+ 446.3, λmax 288 nm.
NMR measurement carried out at Heinrich Heine
Universitat, Dusseldorf, Germany. Deuterated methanol
was used to dissolve samples for NMR measurement. 1D
and 2D NMR spectra were processed and analyzed using
NMR software 1D WIN-NMR and 2D WIN-NMR Bru-
ker NMR suite. NMR spectra were calibrated using solv-
ent signals of their protons. Observed chemical shifts
value (δ) were given in ppm and coupling constant J in
hertz (Hz).
1H NMR of the compound ‘A’ was generated with
methanol-d at 500 MHz and found as δ 5.84 (1H, S),
5.75 (1H, s), 5.59 (1H, s), 5.48 (s), 5.24 (s), 4.38 (1H, d,),
4.29 (1H, dt, J= 7.6, 6.3), 3.81 (dd), 3.62 (1H, d), 2.9
(1H, br s), 2.65 (1H, s), 2.34 (1H, d, J=12), 2.19 (s), 2.13
(1H, d, J= 12.5), 1.92 (3H, d, J= 9.8), 1.74 (3H, br s), 1.61
(5H, s), 1.57 (s), 1.47 (6H, d, J= 10.15), 1.4 (2H, d,
J= 12.2), 1.28 (s), 1.23 (s), 1.18 (s), 0.89 (5H, d, J= 2.8),
0.79 (3H, d, J=4.2). Comparative 1H NMR of the puri-
fied compound and published compound is provided in
Table 5.
Bioassay of extracts/fractions of C. globosum EF18 against
Sclerotinia sclerotiorum
Bioassay of crude extract was done as per the procedure
described by Kumar and Kaushik (2013). Whereas, for
bioassay of fractions 30 mg of dried extract was dis-
solved in 600 μl of methanol and out of this 60, 120 and
300 μl were mixed to 30 ml of media for 100, 200 and
500 μg/ml concentrations. There were 3 replications for
each treatment.
Data analysis
Percent growth inhibition (GI) and analysis of variance
of the GI was performed as described earlier (Kumar
and Kaushik 2013). Concentration at which 50% growth
inhibition occurs i.e. IC50 was calculated by probit
analysis (Finney 1971) using the software SPSS 17.0.
Immersion of liquid 
culture in ethyl acetate
Water phase-extracted twice 
with ethyl acetate
Water phase- extracted thrice 
with saturated butanol 
Dried pooled extract partitioned 




Water phase Butanol extract Hexane extractMethanol extract
Homogenization of the culture 
after 24 hrs of immersion
Filtration and partitioning
(WSL2E)








EtOAc extract of 
WSL2 (WSL2E) 3.5 g
I II III IV V VI VII VIII IX X
Fr. I 21.4 
mg






Sephadex LH 20 column (DCM: MeOH; 50:50)
VLC (silica gel, DCM: MeOH )





Sephadex LH 20 column 100% 
MeOH
43.7 mg
Figure 10 Schematic diagram of procedure of separation/ purification of ethyl acetate extracts of C. globosum isolate EF18 (WSL2E).
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Table 5 Comparison of 1H NMR of purified fraction and compound ‘A’ from literature (Yang et al. 2006)
Atom no. Chemical shift H’ Multiplicity Coupling constant
Compound ‘A’ Literature Compound ‘A’ Literature Compound ‘A’ Literature
8b 0.83 M, 1H
16 0.79 0.85 D 3H D, 3H 4.2 6.5
15 0.89 0.91 D 5H D, 3H 2.8 6.5




9 1.39 M, 1H
10 1.4 1.4 D 2H M, 1H 12.2
24 1.47 1.49 D 6H S, 3H 10.15
14 1.5 Br d, 3H 6.5
12 1.57 1.57 S Br s, 3H
7 1.63 M, 1H
8a 1.61 1.66 S 5H M, 1H
22b 1.74 1.75 BR S 3H Dd, 2H
5 1.85 M, 1H
6a 1.92 1.91 D 3H M, 1H 9.8
2.13 D 1H 12.5
2.19 S
22a 2.34 2.5 D 1H Dd, 1H 12.0 14.0, 2.5
2.65 S 1H
2 2.9 3.00 BR S 1H Dt, 1H 8.0, 1.0, 1.0
3.62 D 1H 12.45
20 3.81 3.8 DD Dd, 1H 10.0, 2.5
1 4.29 3.94 DT 1H Dd, 1H 7.6, 6.3 8.0, 7.0
4.38 D 1H
13 5.24 5.19 S Dq, 1H 6.5, 1.0
5.48 S
3 5.59 5.66 S 1H Br s, 2H
4 5.75 S 1H
5.84 S 1H
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